Anuh Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

222.85

+222.85 (+0.00%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

222.85

+222.85 (+0.00%)
16:02 Dec 20

Quality

88/100
High Financial Strength

Valuation

50/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	431.96	486.65	527.49	647	639.85
Operating Expenses +	387.38	439.8	476.21	571.86	569.19
Raw Material	327.48	382.54	388	501.91	462.95
Increase Decrease in Cost	2.31	-4.86	13.48	-15.24	13.92
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	14.29	15.1	17.15	19.39	20.64
Miscellaneous Expenses	50.26	108.68	79.56	90.16	71.68
Operating Profit	44.58	46.85	51.28	75.14	70.66
Other Income	10.54	5.2	6.11	12.1	13.6
Depreciation	15.08	11.96	9.7	8.58	8.23
Interest	1.49	0.96	0.22	0.35	0.54
Profit before tax and exceptio..	38.55	39.12	47.47	78.31	75.49
Exceptional Items	0	0	0	0	0
PBT	38.55	39.12	47.47	78.31	75.49
Provision for Taxation	10.12	8.56	11.29	18.25	16.46
Net Profit	28.44	30.56	36.18	60.06	59.02
NET Profit after MI	0	0	0	0	0
EPS	5.67	6.1	7.22	11.98	11.77
Operating Profit Margin (%)	10.32	9.63	9.72	11.61	11.04
Net Profit Margin (%)	6.58	6.28	6.86	9.28	9.22

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	69.90	69.80	69.90	69.90	70.60
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	30.10	30.20	30.00	30.00	29.40
Others	0.00	0.00	0.00	0.10	0.00
Others	0.00	0.00	0.10	0.00	0.00